Search

Displaying results 5301 - 5310 of 10000 in total
  1. Drug

    Succinylsulfathiazole

    go.drugbank.com/drugs/DB13580
    Investigational

    Categories: Heterocyclic Compounds, 1-Ring
  2. Drug

    Etamiphylline

    go.drugbank.com/drugs/DB13592
    Experimental

    Categories: Cytochrome P-450 Substrates, Heterocyclic Compounds, 2-Ring
  3. Drug

    Zolimidine

    go.drugbank.com/drugs/DB13593
    Experimental

    Categories: Heterocyclic Compounds, 1-Ring
  4. Drug

    Almasilate

    go.drugbank.com/drugs/DB13595
    Approved

    Almasilate is a buffering antacid that has been used in peptic ulcers and dyspepsia. … It is a crystalline polyhydrate of aluminium/magnesium silicate and mediates its buffering activity by binding hydrogen ions within the polymer.

  5. Drug

    Moroxydine

    go.drugbank.com/drugs/DB13597
    Experimental

    Categories: Heterocyclic Compounds, 1-Ring
  6. Drug

    Promegestone

    go.drugbank.com/drugs/DB13602
    Experimental

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
  7. Drug

    Picloxydine

    go.drugbank.com/drugs/DB13607
    Experimental

    Categories: Heterocyclic Compounds, 1-Ring
  8. Drug

    Umifenovir

    go.drugbank.com/drugs/DB13609
    Investigational

    , including _Flavivirus_,[A191388] Zika virus,[A191391] foot-and-mouth disease,[A191394] Lassa virus,[A191403] Ebola virus,[A191403] herpes simplex,[A191409], hepatitis B and C viruses, chikungunya virus … Its invention is credited to a collaboration between Russian scientists from several research institutes 40-50 years ago, and reports of its chemical synthesis date back to 1993.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates
  9. Drug

    Ticlatone

    go.drugbank.com/drugs/DB13613
    Experimental

    Categories: Heterocyclic Compounds, 1-Ring
  10. Drug

    Mifamurtide

    go.drugbank.com/drugs/DB13615
    ApprovedInvestigational

    Also called L-MTP-PE, mifamurtide may be a liposomal form of of the active ingredient MTP-PE, which is a synthetic, less pyrogenic, and longer-acting derivative of muramyl dipeptide (MDP). … As a liposomal formulation, mifamurtide demonstrates an enhanced tumoricidal effect and improved safety profile [A31745]. Mifamurtide is marketed in Europe as Mepact for intravenous infusion.

    Products: MEPACT 4 MG INFÜZYONLUK DISPERSIYON KONSANTRESI IÇIN TOZ ,FLAKON, 1 ADET, MEPACT® POLVO PARA CONCENTRADO PARA DISPERSIÓN PARA PERFUSIÓN